Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis

Author(s):
Nuland, M. van; Groenland, S.; Bergman, A.M.; Rotmans, J.I. (0000-0001-9682-6234); Rosing, H.; Beijnen, J.H.; Huitema, A.D.R.
Published
2019
Publication type
Article / Letter to editor
EnzalutamideHemodialysisMetabolitesProstate cancerRenal failure
Date issued
2019-04-01
Language
English
Publisher
CIG MEDIA GROUP, LP
Is part of
Clinical Genitourinary Cancer (2019), Vol. 17, no. 2, p. E383-E386
hdl
1887/122901
doi
10.1016/j.clgc.2018.12.004